“Acute pancreatitis”的搜索结果，显示 191-200 项，共有 10046 项

1. 血液科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

2. 神经科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

3. 神经科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

4. 神经科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

5. 神经科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... of MDMs for detection of advanced neoplasia in pancreatic cysts. A Study of ... Safety is defined as any acute grade 3 (CTCAE v5.0) or greater ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Testing The Use Of Chemotherapy After Surgery For High-Risk Pancreatic Neuroendocrine Tumors. Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of this ...

8. 神经科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

9. 神经科- 临床试验- 妙佑医疗国际

   VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ... Pancreatic SPORE, “Optimal Immunotargeting of ... Eligibility Criteria, keep ...

10. 神经科- 临床试验- 妙佑医疗国际

    A total of 8,000 patients presenting to CPSs with acute ... Pancreatic SPORE, “Optimal Immunotargeting of ... Eligibility Criteria, keep current Eligibility ...